Global and China Biodegradable Plastics Industry Report, 2013-2016
  • Mar./2014
  • Hard Copy
  • USD $2,400
  • Pages:102
  • Single User License
    (PDF Unprintable)       
  • USD $2,250
  • Code: ALZ-001
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,400
  • Hard Copy + Single User License
  • USD $2,600
      

Global biodegradable plastic production and demand have grown rapidly in recent years, and the capacity reached 1-1.5 million t/a in 2012-2013. Among dozens of biodegradable plastic varieties developed so far, only plastarch material (PSM), polylactic acid (PLA), poly(butylene succinate) (PBS) have realized mass industrial production. In 2013, PSM, PLA and PBS accounted for 87% of the world’s total capacity.

In 2013, demand from Europe and North America, the two main biodegradable plastic markets around the world, for biodegradable plastics accounted for 54% and 28%, respectively. Germany-based BASF, U.S.-based NatureWorks (Thailand’s PTT Chemical paid US$150 million for a 50% stake in NatureWorks in December 2011), Italy’s Novamont as well as the Netherlands-based Purac are the world’s major suppliers of biodegradable plastics, with capacity of 140 kt/a, 140 kt/a, 80 kt/a, 80 kt/a, respectively.

2014032602.png

China as one of the world’s important suppliers of biodegradable plastics accounts for about 20% of global production capacity. In 2009-2013, its biodegradable plastic capacity grew at a compound annual growth rate of over 21%. And, under the stimulus of favorable national policies as well as expanding range of applications, many domestic enterprises have embarked on new construction or expansion of biodegradable plastics.

As a leader in domestic plastics industry, Kingfa Sci & Tech Co., Ltd. mainly produces modified plastics, specialty engineering plastics, completely biodegradable plastics, carbon fiber and composite materials, of which, the 30 kt/a PBS and polybutylene succinate adipate (PBSA) has been put into operation in Zhuhai in 2011, the Phase II 90 kt/a PBSA expansion project will be launched. Meanwhile, Kingfa is also increasing intensity of downstream demand expansion. The company has signed biodegradable plastic mulch demonstrative application agreements with Xinjiang Production and Construction Corps, Guizhou, Shandong and other provinces and cities in early 2014.

Wuhan Huali Environment Technology Co., Ltd is a national biodegradable material industrial demonstration base, mainly engaged in PSM, ranking first in China’s biodegradable plastics industry with 40 kt/a PSM in 2013. Besides, the company’s 60 kt/a PSM are under construction, expected to be put into operation by mid-2014.

Global and China Biodegradable Plastics Industry Report, 2013-2016 mainly covers the followings:
20120114.gifSupply and demand, product mix, regional structure, competition pattern, development trends of global biodegradable plastics market;
20120114.gifSupply and demand, competition pattern, policies, development trends of Chinese biodegradable plastics market;
20120114.gifDevelopment status, competition pattern of biodegradable plastic product segments such as PSM, PLA, PHA, PBS;
20120114.gifOperation, biodegradable plastics business analysis and development of more than 20 domestic and foreign biodegradable plastics manufacturers.

1. Overview of Biodegradable Plastics Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain 

2. Global Biodegradable Plastics Market
2.1 Market Supply
2.2 Global Demand
2.3 Product Mix
2.4 Regional Structure
2.4.1 USA
2.4.2 Europe
2.4.3 Japan
2.4.4 Brazil
2.4.5 Thailand
2.5 Technology Trends
2.6 Competition Pattern
2.7 Development Trends

3. China Biodegradable Plastics Market
3.1 Market Supply
3.2 Market Demand
3.3 Competition Pattern
3.4 Policy Trends
3.5 Development Trends

4. Biodegradable Plastics Market Segments
4.1 Plastarch Material (PSM)
4.1.1 Development Status
4.1.2 Competition Pattern
4.2 Polylactic Acid (PLA)
4.2.1 Introduction
4.2.2 Development Status
4.2.3 Competition Pattern
4.3 Polyhydroxyalkanoates (PHA)
4.3.1 Development Status
4.3.2 Competition Pattern
4.4 Poly(Butylene Succinate) (PBS)
4.4.1 Introduction
4.4.2 Competition Pattern
4.5 Others
4.5.1 Polycaprolactone (PCL)
4.5.2 Polypropylene Carbonate (PPC)
4.5.3 Aliphatic-Aromatic Copolyester
4.5.4 Polyvinyl Alcohol (PVA)

5. Main Companies in the World
5.1 BASF
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 R&D and Investment
5.1.6 Biodegradable Plastics Business
5.1.7 Business in China
5.1.8 Development Prospect
5.2 NatureWorks LLC
5.2.1 Profile
5.2.2 Business in China 
5.3 Novamont
5.4 Dupont
5.5 Mitsubishi Chemical
5.6 Showa Denko
5.7 PURAC
5.7.1 Profile
5.7.2 Production
5.7.3 Operation

6. Main Companies in China
6.1 Kingfa Sci & Tech Co., Ltd. (600143)
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 Clients and Suppliers
6.1.6 PBS Biodegradable Plastics Business
6.1.7 R&D
6.1.8 Development Prospect
6.2 Zhejiang Hangzhou Xinfu Pharmaceutical Co., Ltd. (002019)
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 Clients and Suppliers
6.2.6 PBS Biodegradable Plastics Business
6.2.7 R&D
6.2.8 Development Prospect
6.3 Wuhan Huali Environment Technology Co., Ltd.
6.3.1 Profile
6.3.2 Operation
6.3.3 Development Prospect
6.4 Anqing Hexing Chemical Co., Ltd
6.4.1 Profile
6.4.2 Operation
6.4.3 Development Prospect
6.5 Others
6.5.1 Zhejiang Hisun Biomaterials Co., Ltd.
6.5.2 Ningbo Tianan Biologic Material Co., Ltd.
6.5.3 Zhejiang Tianhe Environmental Technology Co., Ltd.
6.5.4 Henan Yongle Biological Engineering Co., Ltd.
6.5.5 Maanshan Tong-Jie-Liang Biomaterials Co., Ltd.
6.5.6 Zhejiang Wafa Ecosystem Science & Technology Co., Ltd.  
6.5.7 Fujian Beststarch Biodegradable Material Co., Ltd.
6.5.8 Guangdong Shangjiu Biodegradable Plastics Co., Ltd.
6.5.9 Shandong Fuwin New Material Co., Ltd.
6.5.10 Tianjin Danhai Co., Ltd.
6.5.11 Zibo Qixiang Tengda Chemical Co., Ltd (002408)
6.5.12 Tianjin GreenBio Materials Co., Ltd.
6.5.13 Shenzhen BrightChina Industrial Co., Ltd.

7. Summary and Forecast
7.1 Summary
7.2 Supply and Demand Forecast
7.3 Plastic Film Forecast
Classification and Usage of Biodegradable Plastics (by Raw Materials)
Biodegradable Plastics Industry Chain
Capacity of Global Biodegradable Plastics and Non-biodegradable Plastics, 2010-2013
Global Bioplastic Capacity Structure by Variety, 2012
Global Biodegradable Plastic Demand and Growth Rate, 2005-2013
Global Biodegradable Plastic Demand Structure by Usage, 2013
Global Biodegradable Plastic Capacity Structure by Variety, 2013
Global Biodegradable Plastic Demand Structure by Region, 2013
Global Biodegradable Plastic Capacity Structure by Region, 2013
Major Events of Japanese Enterprises Engaged in Biodegradable Plastic Application Development, 2008-2013
Biodegradable Plastic Technology Development, 2008-2014
Capacity of Main Biodegradable Plastic Enterprises in the World, 2013
China’s Biodegradable Plastic Capacity and Growth Rate, 2009-2014
China’s Plastic Film Production and YoY Growth, 2005-2013
China’s Agricultural Film Production and YoY Growth, 2005-2013
Biodegradable Plastics Substitution for Plastic Film and Agricultural Film in China, 2012
Capacity of Main Biodegradable Plastics Enterprises in China, 2013 
Policies of China’s Bioplastics Industry, 2006-2013
Main Constituents and Source of PSM
Capacity Distribution of PSM Companies in the World, 2010-2020
Properties and Applications of PLA 
Capacity of Main PLA Companies in the World, 2010-2020
Main Application of PHA in Medicine
Evolution of PHA
Capacity of Main PHA Companies in the World, 2010-2020
Capacity of Main PBS Companies in the World, 2010-2020
Main PPC Companies in China, 2013
BASF’s Structure by Business, 2013
Sales and YoY Growth of BASF, 2002-2013
Net Income and YoY Growth of BASF, 2002-2013
Sales Breakdown of BASF by Business, 2012-2013
Sales Breakdown of BASF by Region, 2012-2013
Sales Structure of BASF by Region, 2013
Gross Margin and YoY Growth of BASF, 2006-2013
R&D Expenditures of BASF, 2009-2013
Number of New Patents
R&D Cost Structure of BASF by Department, 2013
BASF’s Key Projects under Construction
Constituents and Applications of Ecoflex and Ecovio
Product Categories and Applications of BASF’s Performance Polymers
Production and R&D Bases of BASF in China, 2013
Regional Distribution of BASF Companies in China, 2013
Sales and Growth Rate of BASF in China, 2007-2013
Sales and Net Income of BASF, 2011-2016
Main Products and Business Areas of PURAC, 2013
PURAC Production Plants, 2013
Distribution of PURAC Plants and Sales Offices, 2013
Sales and EBIT of PURAC, 2008-2015E
Sales Structure of PURAC by Sector, 2013
Capital Expenditure and Return on Investment of PURAC, 2009-2012
R&D Costs and % of Total Revenue of Kingfa, 2011-2013
Total Assets and Net Income of Xinfu Pharmaceutical-controlled Subsidiaries by Jun. 2013
Revenue and YoY Growth of Xinfu Pharmaceutical, 2006-2013
Net Income and YoY Growth of Xinfu Pharmaceutical, 2006-2013
Revenue Breakdown of Xinfu Pharmaceutical by Product, 2006-2013
Gross Margin of Xinfu Pharmaceutical by Product, 2006-2013
Xinfu Pharmaceutical’s Procurement from Top 5 Suppliers and % of Total Procurement, 2006-2012
Xinfu Pharmaceutical’s Revenue from Top 5 Clients and % of Total Revenue, 2006-2013
Revenue and Net Income of PBS Products of Xinfu Pharmaceutical, 2011-2013
R&D Costs and % of Total Revenue of Xinfu Pharmaceutical, 2008-2013
Revenue, Net Income and Growth Rate of Xinfu Pharmaceutical, 2011-2016E
Revenue and Total Profit of Wuhan Huali Environment Technology, 2007-2011
Revenue and Total Profit of Anqing Hexing Chemical, 2007-2008
Global Biodegradable Plastic Demand and Production Structure by Region, 2013
Biodegradable Plastic Capacity Comparison between Domestic and Foreign Enterprises, 2010-2020
China’s Production of Plastic Film and Agricultural Film, 2010-2016E

China Animal Vaccine Industry Report, 2019-2025

Chinese animal vaccine industry showed a CAGR of 8% between 2013 and 2017, but it was depressed by the outbreak of African Swine Fever in 2018 with the market size edging down 2.5% on an annualized ba...

China Blood Product Industry Report, 2020-2026

With the dynamic adjustment in the catalog of medicines covered by national medical insurance system, the scope of clinical use of almost all blood products grows tremendously, so does the reimburseme...

China Vacuum Blood Collection Device Industry Report, 2019-2025

As laboratory medicine advances, favorable polices are issued and people live a better life and care more about their health, vacuum blood collection systems get increasingly used. In 2018, global vac...

China Human Vaccine Industry Report, 2019-2025

China has been the world’s biggest producer and consumer of human vaccines over four decades of planned vaccination, a program that has reduced incidence of multiple vaccine-targeted infectious diseas...

China Independent Clinical Laboratory Industry Report, 2019-2025

China's independent clinical laboratory industry is still in its infancy. In 2018, it only saw the penetration rate of about 5%, far below 40% or more in Europe, the United States and Japan. The main ...

Global and China Monoclonal Antibody Industry Report, 2019-2025

Global monoclonal antibody market can be presented as follows: 1. Monoclonal antibody drug market booms and is highly concentrated with the approvals for such drugs.Monoclonal antibody drugs have bee...

China Contract Research Organization (CRO) Industry Report, 2019-2025

The steadily growing global pharmaceutical industry where more and more new drugs have been approved, and the soaring spending on drug research and development in recent years, are a boon for global c...

China Blood Product Industry Report, 2019-2025

With the adjustment of the national medical insurance catalogue, the clinical application and reimbursement rate of almost all blood products have been greatly improved, and the market for blood produ...

China Human Vaccine Industry Report, 2018-2022

As the world’s largest producer of human vaccines, China has established a full-life-cycleregulatory system covering vaccine R&D, production, distribution, and vaccination. The lot release volum...

China Contract Research Organization(CRO) Industry Report, 2017-2021

Under the pressure from higher R&D costs, longer R&D cycle and lower R&D success rate in pharmaceutical industry worldwide, over 50 percent of pharmaceutical enterprises have had the devel...

China Vacuum Blood Collection Device Industry Report, 2017-2021

China’s vacuum blood collection device industry now flourishes after start-up and growth stages. Along with steady improvement in economic environment, rising per-capita disposable income, greater awa...

China Independent Clinical Laboratory Industry Report, 2017-2021

China's independent clinical laboratory industry started late, and is still in its infancy. In 2016, it only saw the penetration rate of about 4%, far below 40% or more in Europe, the United States an...

China Human Vaccine Industry Report, 2017-2021

The human vaccine industry presented the following main characteristics in 2016 in China: 1. Lot release volume of human vaccines declined.Affected by the illegal vaccine case in Mar 2016 in Shandong...

China Independent Clinical Laboratory Industry Report, 2016-2020

Owing to a large population base, uneven distribution of medical resources among regions, aging population, and continuous advance of health care reform, the Chinese independent clinical laboratory ma...

China Human Vaccine Industry Report, 2016-2020

Amid the unsafe domestic vaccine events, China’s human vaccine lot release volume in 2015 fell by 17.9% year on year to only 650 million doses,touching a 5-year low. Moreover, with the improvements in...

China Animal Vaccine Industry Report, 2016-2020

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. In recent years, European and American animal vaccine markets have seen ...

China Blood Product Industry Report, 2016-2019

Recombinant blood products have developed for many years in foreign countries, but China’s blood products are still proteins extracted from human blood. Thus, reserves and control of plasma resources ...

China Contract Research Organization (CRO) Industry Report, 2015-2018

In recent years, China's contract research organization (CRO) industry has developed rapidly, with the market size rising from RMB8.5 billion in 2007 to RMB42.6 billion in 2014, registering a CAGR of ...

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号